Form 8-K - Current report:
SEC Accession No. 0001829126-25-005276
Filing Date
2025-07-22
Accepted
2025-07-22 16:30:28
Documents
12
Period of Report
2025-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 26280
  Complete submission text file 0001829126-25-005276.txt   188924

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20250717.xsd EX-101.SCH 2990
3 XBRL LABEL FILE opgn-20250717_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE opgn-20250717_pre.xml EX-101.PRE 22342
14 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3543
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 251140617
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)